Molnupiravir: COVID drug linked to mutations that could 'spread the illness', scientists say
- A study has found that the antiviral drug molnupiravir can cause mutations in the COVID-19 virus, potentially leading to further infection and genetic diversity in the surviving viral population.
- These mutations were more likely in older age groups, which aligns with the use of antiviral treatment in higher-risk individuals.
- The findings of the study have raised questions about the overall benefits and risks of molnupiravir and similar drugs, urging regulators to consider the possibility of persistent antiviral-induced mutations when developing new treatments.
Insights by Ground AI
Does this summary seem wrong?
More
Filters
Filters
29 Articles
29 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left7Leaning Right3Center16Last Updated2 months agoBias Distribution62% Center
Bias Distribution
- 62% of the sources are Center
58% Center
L 29%
C 58%
13%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage